Vicapsys Life Sciences VICP Growth Metrics (2019-2024)

OTC VICP
$0.79 -0.06 (-7.06%)
At close: Sep 25, 2026 · 4:00 PM EDT
Reported Financials

Vicapsys Life Sciences Quarterly Growth Metrics

Periods 22 quarters
Latest Sep 2024

Vicapsys Life Sciences reported asset growth of -57.04% for the quarter ended Sep 2024. These growth metrics cover 22 quarters of results from Jun 2019 through Sep 2024, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024
Growth Ratios
Assets Growth (1y)
-42.14%-7.08%31.58%33.28%47.06%11.62%-32.04%-30.49%-87.88%-86.76%-1.06%-45.68%-44.94%-57.04%
Assets Growth (3y)
-53.11%-48.41%-4.00%-20.46%-53.88%-45.46%
Assets (QoQ)
-33.99%-7.29%-3.07%-2.45%6.01%31.28%-1.82%7.63%-19.54%-20.07%0.42%-81.23%-12.12%497.45%-44.87%-80.98%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
-99.52%-1.57%3,322.06%9,909.01%17,023.33%232.60%-89.87%-84.17%-93.51%-95.91%1,237.71%104.24%-33.16%67.32%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
-62.35%-48.86%259.30%218.68%95.09%-18.52%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
-88.28%-83.89%-66.83%-23.28%2,300.55%460.10%-2.97%31.26%-53.37%-82.94%51.60%-46.22%-70.63%5,486.40%-76.85%-82.40%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
-24.23%86.64%99.02%99.84%69.64%-169.00%-5,304.41%-31,914.03%-63.79%-20.32%77.19%102.34%91.41%-159.55%-161.47%-2,941.20%5.37%102.83%62.36%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
14.83%24.38%50.65%26.24%65.05%-103.29%-218.26%-497.33%48.95%27.82%39.22%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
45.03%15.23%34.74%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
27.87%5.38%88.87%87.17%88.45%-18,291.17%1.37%-157.84%31.55%5.90%27.55%51.11%107.03%-444.77%-2,090.45%50.75%23.61%88.52%165.44%-755.71%
EBIT Growth (1y)
-122.78%-53.04%80.99%67.73%86.34%68.89%-24.61%-28.94%-235.64%-149.86%-30.49%-374.31%-26.48%24.64%-20.91%-7.02%3.32%-34.01%-13.36%
EBIT Growth (3y)
-0.70%-5.96%32.39%-25.43%16.62%16.32%-25.28%-87.06%-60.10%-36.14%-21.39%
EBIT Growth (5y)
-4.54%-3.74%15.78%
EBIT (QoQ)
46.81%-46.00%36.45%61.48%9.72%38.21%-44.79%-54.29%6.59%-60.84%-7.79%19.42%-239.54%57.11%35.77%-29.28%-200.53%61.26%10.97%-9.36%
EBT Growth (1y)
-122.78%-53.04%80.99%67.73%113.78%68.89%-24.61%-28.94%-432.56%-149.86%-30.49%-374.31%-26.48%24.64%-65.66%-20.75%-54.81%-40.09%2.01%
EBT Growth (3y)
-0.70%-5.96%32.39%-25.43%16.62%16.32%-39.14%-94.73%-104.17%-38.17%-28.43%
EBT Growth (5y)
-14.86%-4.66%12.88%
EBT (QoQ)
46.81%-46.00%36.45%61.48%9.72%162.36%-243.46%-54.29%6.59%-60.84%-7.79%19.42%-239.54%57.11%35.77%-77.12%-147.48%45.01%41.88%-23.89%
EPS (Basic) Growth (1y)
66.65%46.33%86.97%39.48%114.37%68.93%-24.44%55.60%-294.28%-40.26%24.96%-173.88%-5.00%33.44%-46.59%-6.87%-66.94%-44.70%1.79%
EPS (Basic) Growth (3y)
54.68%38.39%50.45%9.72%33.58%33.81%-11.03%-9.13%-75.50%-10.54%-2.61%
EPS (Basic) Growth (5y)
30.41%25.78%29.42%
EPS (Basic) (QoQ)
44.10%4.77%36.45%61.48%-159.60%122.60%-237.45%-54.29%7.38%1.09%0.77%17.45%-238.05%62.08%37.10%-81.80%-146.46%40.76%45.48%-23.39%
EPS (Diluted) Growth (1y)
107.78%68.93%-24.44%55.22%-458.89%-40.26%24.96%-171.56%-5.00%33.44%-46.59%-6.87%-66.94%-44.70%1.79%
EPS (Diluted) Growth (3y)
33.58%33.81%-11.03%-9.13%-102.40%-10.54%-2.61%
EPS (Diluted) (QoQ)
36.45%61.48%-159.60%112.24%-353.91%-54.29%6.59%1.93%0.77%17.45%-238.05%62.08%37.10%-81.80%-146.46%40.76%45.48%-23.39%
Free Cash Flow Growth (1y)FCF Growth (1y)
-24.23%86.64%99.02%99.84%69.64%-169.00%-5,304.41%-31,914.03%-63.79%-20.32%77.19%102.34%91.41%-159.55%-161.47%-2,941.20%5.37%102.83%62.36%
Free Cash Flow Growth (3y)FCF Growth (3y)
14.83%24.38%50.65%26.24%65.05%-103.29%-218.26%-497.33%48.95%27.82%39.22%
Free Cash Flow Growth (5y)FCF Growth (5y)
45.03%15.23%34.74%
Free Cash Flow (QoQ)FCF (QoQ)
27.87%5.38%88.87%87.17%88.45%-18,291.17%1.37%-157.84%31.55%5.90%27.55%51.11%107.03%-444.77%-2,090.45%50.75%23.61%88.52%165.44%-755.71%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
69.21%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
-221.36%90.12%-294.06%75.38%
Net Cash Flow Growth (1y)NCF Growth (1y)
-180.18%-106.07%-104.18%99.84%112.52%-169.00%-52.31%13,540.52%-497.26%-20.32%-709.44%-123.41%91.41%-159.55%-332.69%-264.15%5.37%102.83%150.39%
Net Cash Flow Growth (3y)NCF Growth (3y)
-11.69%-29.99%-35.99%63.37%65.05%-103.29%-276.44%-385.69%-32.43%27.82%169.84%
Net Cash Flow Growth (5y)NCF Growth (5y)
35.32%-57.17%2.34%
Net Cash Flow (QoQ)NCF (QoQ)
-408.87%5.38%88.87%87.17%88.45%7,682.86%-339.22%92.73%1,119.63%-324.13%27.55%51.11%70.51%17.80%-2,090.45%18.50%75.18%78.64%165.44%1,352.63%
Net Income Growth (1y)
17.67%6.63%80.99%67.73%113.78%68.89%-24.61%-28.94%-432.56%-149.86%-30.49%-374.31%-26.48%24.64%-65.66%-20.75%-54.81%-40.09%2.01%
Net Income Growth (3y)
27.74%10.13%32.39%-25.43%16.62%16.32%-39.14%-94.73%-104.17%-38.17%-28.43%
Net Income Growth (5y)
5.87%5.18%12.88%
Net Income (QoQ)
46.81%-46.00%36.45%61.48%9.72%162.36%-243.46%-54.29%6.59%-60.84%-7.79%19.42%-239.54%57.11%35.77%-77.12%-147.48%45.01%41.88%-23.89%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
39.57%6.63%80.99%7.22%114.38%68.89%-24.61%55.16%-418.83%-149.86%-33.68%-374.31%-26.48%24.64%-61.70%-20.75%-54.81%-40.09%2.01%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
34.82%10.13%31.84%-25.43%16.62%16.32%-39.14%-36.94%-102.00%-38.17%-28.43%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
11.52%5.18%12.88%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
46.81%-46.00%36.45%61.48%-159.60%122.62%-237.54%-54.29%6.59%-60.84%-7.79%17.45%-231.43%57.11%35.77%-77.12%-147.48%45.01%41.88%-23.89%
Operating Income Growth (1y)Op. Inc Growth (1y)
86.34%68.89%-24.61%-28.94%-235.64%-149.86%-30.49%-374.31%-26.48%24.64%-20.91%-7.02%3.32%-34.01%-13.36%
Operating Income Growth (3y)Op. Inc Growth (3y)
16.62%16.32%-25.28%-87.06%-60.10%-36.14%-21.39%
Operating Income (QoQ)Op. Inc (QoQ)
36.45%61.48%9.72%38.21%-44.79%-54.29%6.59%-60.84%-7.79%19.42%-239.54%57.11%35.77%-29.28%-200.53%61.26%10.97%-9.36%
Profit After Tax Growth (1y)PAT Growth (1y)
-122.78%-53.04%80.99%67.73%113.78%68.89%-24.61%-28.94%-432.56%-149.86%-30.49%-374.31%-26.48%24.64%-65.66%-20.75%-54.81%-40.09%2.01%
Profit After Tax Growth (3y)PAT Growth (3y)
-0.70%-5.96%32.39%-25.43%16.62%16.32%-39.14%-94.73%-104.17%-38.17%-28.43%
Profit After Tax Growth (5y)PAT Growth (5y)
-14.86%-4.66%12.88%
Profit After Tax (QoQ)PAT (QoQ)
46.81%-46.00%36.45%61.48%9.72%162.36%-243.46%-54.29%6.59%-60.84%-7.79%19.42%-239.54%57.11%35.77%-77.12%-147.48%45.01%41.88%-23.89%
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
14,531.0025,735.0018,383.0014,584.00-33.00-9199.00-11730.00-39077.00-143625.00-31544.00-21255.00-52068.00
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
-129126.00-15008.00-14602.00-76561.00
Return on Assets [ROA] (QoQ)ROA (QoQ)
-6636.007,388.003,500.0010,280.004,568.0035.00-300.00-4337.00-4598.00-2495.00-27647.00-108884.00107,482.007,794.00-58460.00
Return on Equity [ROE] (QoQ)ROE (QoQ)
-77969.00
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
-79.99%-79.99%-80.01%-62.50%0.00%-0.09%0.00%3,729.32%5,638.72%1,814.62%383.16%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
125.60%56.42%352.12%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
0.00%0.00%-46.69%-62.47%0.00%-0.09%0.00%0.09%-0.09%0.00%3,729.32%50.00%-66.67%
Total Debt Growth (1y)
115.10%89.08%
Total Debt (QoQ)
29.48%23.92%34.06%0.00%13.82%

Vicapsys Life Sciences Growth Metrics API

Pull Vicapsys Life Sciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=VICP&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY